PT1027055E - Derivados de 3-carboalcoxi-2,3-di-hidro-1h-fenotiazina-4¬10h|-ona - Google Patents
Derivados de 3-carboalcoxi-2,3-di-hidro-1h-fenotiazina-4¬10h|-onaInfo
- Publication number
- PT1027055E PT1027055E PT98955131T PT98955131T PT1027055E PT 1027055 E PT1027055 E PT 1027055E PT 98955131 T PT98955131 T PT 98955131T PT 98955131 T PT98955131 T PT 98955131T PT 1027055 E PT1027055 E PT 1027055E
- Authority
- PT
- Portugal
- Prior art keywords
- carboalcoxy
- phenotiazine
- dihydro
- derivatives
- coor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/958,320 US5994349A (en) | 1997-10-27 | 1997-10-27 | 3-carboalkoxy-2, 3-dihydro-1H-phenothiazin-4[10H]-one derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1027055E true PT1027055E (pt) | 2004-05-31 |
Family
ID=25500854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98955131T PT1027055E (pt) | 1997-10-27 | 1998-10-27 | Derivados de 3-carboalcoxi-2,3-di-hidro-1h-fenotiazina-4¬10h|-ona |
Country Status (11)
Country | Link |
---|---|
US (1) | US5994349A (pt) |
EP (1) | EP1027055B1 (pt) |
AT (1) | ATE257382T1 (pt) |
AU (1) | AU748596B2 (pt) |
CA (1) | CA2308281C (pt) |
DE (1) | DE69821019T2 (pt) |
DK (1) | DK1027055T3 (pt) |
ES (1) | ES2212370T3 (pt) |
IL (1) | IL135842A (pt) |
PT (1) | PT1027055E (pt) |
WO (1) | WO1999021560A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201536795A (zh) | 2013-05-31 | 2015-10-01 | Medeia Therapeutics Ltd | 作為細胞保護劑用之芳基噻嗪化合物 |
CN106117247B (zh) * | 2016-06-29 | 2018-02-16 | 东华大学 | 一种2‑甲基‑1,2,3,9‑四氢苯并[b]吡咯[1,4]‑噻嗪‑1,3‑二酮类化合物的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3229122A1 (de) * | 1982-08-04 | 1984-02-09 | Bayer Ag, 5090 Leverkusen | Anellierte 4h-1,4-benzothiazine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE3426564A1 (de) * | 1984-07-19 | 1986-01-30 | Bayer Ag, 5090 Leverkusen | Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind |
US5580894A (en) * | 1996-01-11 | 1996-12-03 | Howard University | Isoxazolyl enaminones |
-
1997
- 1997-10-27 US US08/958,320 patent/US5994349A/en not_active Expired - Fee Related
-
1998
- 1998-10-27 CA CA002308281A patent/CA2308281C/en not_active Expired - Fee Related
- 1998-10-27 PT PT98955131T patent/PT1027055E/pt unknown
- 1998-10-27 IL IL13584298A patent/IL135842A/en not_active IP Right Cessation
- 1998-10-27 DE DE69821019T patent/DE69821019T2/de not_active Expired - Fee Related
- 1998-10-27 WO PCT/US1998/022693 patent/WO1999021560A1/en active IP Right Grant
- 1998-10-27 ES ES98955131T patent/ES2212370T3/es not_active Expired - Lifetime
- 1998-10-27 EP EP98955131A patent/EP1027055B1/en not_active Expired - Lifetime
- 1998-10-27 AU AU12013/99A patent/AU748596B2/en not_active Ceased
- 1998-10-27 DK DK98955131T patent/DK1027055T3/da active
- 1998-10-27 AT AT98955131T patent/ATE257382T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1027055A4 (en) | 2001-12-05 |
DE69821019D1 (en) | 2004-02-12 |
DK1027055T3 (da) | 2004-04-26 |
DE69821019T2 (de) | 2004-10-28 |
WO1999021560A1 (en) | 1999-05-06 |
CA2308281A1 (en) | 1999-05-06 |
IL135842A0 (en) | 2001-05-20 |
CA2308281C (en) | 2004-08-24 |
ES2212370T3 (es) | 2004-07-16 |
AU1201399A (en) | 1999-05-17 |
US5994349A (en) | 1999-11-30 |
AU748596B2 (en) | 2002-06-06 |
EP1027055A1 (en) | 2000-08-16 |
ATE257382T1 (de) | 2004-01-15 |
EP1027055B1 (en) | 2004-01-07 |
IL135842A (en) | 2004-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0498069T3 (da) | Ny anvendelse af peptidderivat | |
CA2298033A1 (en) | Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives | |
NO20030885D0 (no) | Inhibitorer av <alfa>4 styrt celleadhesjon | |
YU34896A (sh) | Supstituisani n-(indol-2-karbonil)-glicinamidi, njihovi intermedijeri i farmaceutske kompozicije | |
PT870768E (pt) | Derivados azaindole-etilamina como agentes de ligacao nicotinicos aos receptores de acetilcolina | |
IL131172A0 (en) | 1-Phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands (d4) | |
GB9711650D0 (en) | Compounds useful in therapy | |
TR199902897T2 (xx) | S�v� benz-izo-kuinolin t�revleri. | |
DE69728544D1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
ES2110260T3 (es) | Androstenonas. | |
ATE33831T1 (de) | Analgesia wirkende 5-hydroxytryptophan-derivate. | |
DK0791005T3 (da) | Inhibitorer af proliferation af glatte muskelceller | |
IE861633L (en) | Carboxamide indole derivatives | |
NO995935D0 (no) | 17<beta>-allyloksy(tio)alkyl-androstan-derivater for modulering av meiose | |
PT1027055E (pt) | Derivados de 3-carboalcoxi-2,3-di-hidro-1h-fenotiazina-4¬10h|-ona | |
ES2104370T3 (es) | Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion. | |
MY104955A (en) | Pyrroloquinoline and pyrrolophemothiazine carboxamides and related compounds. | |
DK0476854T3 (da) | Farmaceutisk komposition til at hæmme blodpladeaggregation | |
IE812498L (en) | Pyrimidine derivatives. | |
AU5427486A (en) | New 8-thiotetrahydroquinoline derivatives and salts thereof | |
YU200791A (sh) | Trifluorometil 1-karba (1-detia) cefemi | |
CO5140085A1 (es) | Derivados terapeuticos de benzamida | |
HK1005732A1 (en) | Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents | |
AU551901B2 (en) | Substituted thienobenzodiazepinones | |
CO4920233A1 (es) | Acidos aminobutiricos gamma substituidos como agentes farmaceuticos |